⌘K

Home/Filings/4/0001213900-24-099632

4//SEC Filing

Shah Vinay 4

Accession 0001213900-24-099632

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:01 PM ET

Size

5.6 KB

Accession

0001213900-24-099632

Insider Transaction Report

Form 4

Period: 2024-11-16

ADIAL PHARMACEUTICALS, INC.ADIL

Chief Financial Officer

Transactions

Award
Stock Option
2024-11-16+40,000→ 40,000 total
Exercise: $1.06From: 2024-11-16Exp: 2034-11-15→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001753078

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:01 PM ET
Size: 5.6 KB

View on SEC.gov